Cardiovascular disease in diabetes, beyond glucose

Cell Metab. 2021 Aug 3;33(8):1519-1545. doi: 10.1016/j.cmet.2021.07.001. Epub 2021 Jul 21.

Abstract

Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atherosclerosis* / pathology
  • Blood Glucose
  • Cardiovascular Diseases* / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose
  • Hyperglycemia* / complications
  • Hyperglycemia* / drug therapy
  • Hypoglycemic Agents / therapeutic use
  • Mice
  • Risk Factors

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Glucose